Stocktoria
GeneDx Holdings Corp. WGS
Nasdaq · XNAS · stock · Services-Health Services · website · IPO 2020-09-04
GeneDx Holdings Corp. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 69.7% | 63.6% | 44.4% | -11.4% | -7.8% |
| Operating margin | -3.1% | -7.6% | -89.2% | -284.5% | -210.3% |
| Net margin | -4.9% | -17.1% | -86.8% | -233.9% | -115.6% |
| FCF margin | 3.3% | -11.1% | -91.5% | -139.0% | -94.2% |
| Return on assets | -4.0% | -12.5% | -42.0% | -111.8% | -44.3% |
| Return on equity | -6.8% | -21.3% | -77.1% | -216.4% | -63.2% |
| Debt / equity | 0.18× | 0.23× | 0.25× | 0.04× | 0.03× |
| Current ratio | 2.46 | 3.61 | 3.10 | 1.47 | 4.77 |
| Revenue growth | 40.0% | 50.8% | -13.7% | 10.6% | 18.3% |
Source: SEC EDGAR filings · CIK 0001818331 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.